BA

Bhushan Ashok Karode

Active Director Designated Partner DIN 11137414
DIN 11137414 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhushan Ashok Karode

Data last updated:

Bhushan Ashok Karode is a Designated Partner at Syngenic Pharma Llp (since 2025) and Designated Partner at Syngenic Bioscience Llp (since 2025).

DIN 11137414
Primary Designation Designated Partner
First Appointment 03 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Aug 20252025Active
Designated Partner03 Jun 20252025Active

Board colleagues of Bhushan Ashok Karode

NameDINCompanyDesignation
Chetan Mansukhbhai Hirapara11371359Syngenic Pharma Llp , Syngenic Bioscience LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Syngenic Pharma Llp
Syngenic Bioscience Llp
Premium access

Shareholding and investment profile for Bhushan Ashok Karode

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhushan Ashok Karode

Bhushan Ashok Karode currently holds 2 directorships: Syngenic Pharma Llp (Designated Partner, since 12 Aug 2025); Syngenic Bioscience Llp (Designated Partner, since 03 Jun 2025).

Bhushan Ashok Karode was first appointed on 03 Jun 2025 as Designated Partner at Syngenic Bioscience Llp.

The current boards of Bhushan Ashok Karode's companies include Chetan Mansukhbhai Hirapara (Syngenic Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available